Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 718296 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
EnterprisewideAdd to Basket
Live



Aneurysm Flow Modulating Device Market Current Status & Strategic Opportunities
Medtech Reports, Aug 2009, Pages: 80


  Description  
  Table of Contents  
  Companies Mentioned  
    
    
     
 Enquire before Buying  
 Send to a Friend  

With ev3 valuing Chestnut Medical Pipeline Embolization Device Technology at $150 million and forecasting a market of $350 million for cerebral flow diversion devices by 2013, the floodgates for innovation in the paradigm-shifting field of aneurysm flow modulation have just been blown away.

The unmet medical need is vast, from difficult to coil wide-necked cerebral aneurysms to hard-to-repair thoraco-abdominal aortic aneurysms, and the technology is proving itself to be safe, logical and accessible to small & medium size entrepreneurial start-ups.

Endovascular treatment of aneurysms has evolved substantially over the past two decades, transitioning from an investigational therapy into routine clinical practice and ultimately emerging as the treatment of choice for many lesions.

To date, endovascular therapy has been almost exclusively focused on filling the aneurysm sac with embolic material (coils or liquid embolics) or bridging the aneurysm with a covered stent (Stent Graft).

The idea behind the use of endovascular flow modulating (diverting) devices as monotherapy for endovascular aneurysm repair stems from the concept that a low porosity stent bridging the aneurysm neck modulates hemodynamic flow away from the vortex and streamlines blood flow within parent artery.

Dedicated flow diverting devices for eliminating cerebral aneurysms from circulation without the need for coils have already been cleared for marketing in Europe since mid-2008 and dedicated flow modulating devices for peripheral aneurysm repair entered the European market in 2009.

The market for aneurysm flow modulating devices is still in the embryonic stage with windows of opportunities opening for early entrants. Due to the novelty of the paradigm-shifting technology, little notice was taken of the market potential by large multinationals until ev3 adopted, and started publicizing the technology.

The hypothesis that wall shear stress modulates endothelial cellularity is gaining increasing support from researchers in the field. However, few companies are currently developing dedicated flow modulating devices with designs that take into consideration hemodynamic flow and endothelial growth dynamics.

Aneurysm Flow Modulating Device Market - Current Status & Strategic Opportunities is the first report to cover the market of flow-diverting devices for aneurysm reconstruction and repair.

The report is an exclusive introduction to this emerging market and provides a thorough, analysis of both the technology and markets with analysis of existing markets for cerebral, abdominal aortic, thoracic aortic and peripheral aneurysms, profiles of leading participants and forecasts to the year 2015.

With Aneurysm Flow Modulating Device Market - Current Status & Strategic Opportunities, you’ll be able to better:

- Assess market size and growth potential for aneurysm flow diverting devices.

- Identify emerging technologies and the companies behind them.

- Leverage your own technology and brainstorm new business opportunities.

- Understand current market dynamics, competitors’ positions and market shares.

- Assess market potential and have access to forecasts till 2015.

- Monitor the competition’s marketed and in-development products.

- Investigate mergers, acquisitions and licensing possibilities.

- Get a feel of the magnitude of the opportunity that fluid diverting devices presents and contemplate your company position towards this market transforming technology.

Aneurysm Flow Modulating Device Market - Current Status & Strategic Opportunities is targeted at senior executives in medical technology companies who are interested in developing an understanding of this emerging growth area.


Customers who bought this item also bought

Endovascular Aneurysm Repair Device Market - Paradigm Shift & Strategic Opportunities

IntraCranial Stents Market - Technology & Market Forecast

Neuro Endovascular Market - Strategic Assessment & Trend Analysis

Endovascular Cerebral Aneurysm Repair Market

Endovascular Abdominal Aortic Aneurysm Repair Device Market - Technology Update & Market Forecast

Endovascular Thoracic Aortic Aneurysm Repair Device Market - Technology Update & Market Forecast

Endovascular Thoracic Aortic Aneurysm Repair Device Market 2010 Edition - Technology Update & Market Forecast

Neuro Stents & Coils Technology & Market Forecast

Carotid Artery Angioplasty & Stenting Technology & Market Forecast

Aortic EndoGraft Market Current Situation & Future Outlook

US Markets for Transcatheter Embolization & Occlusion Devices 2010-2014

Abdominal Aortic Aneurysm Pipeline Product and Technology Analysis Report



Top of page


   All rights reserved. © Copyright 2010 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds